🔵 What do we do?Multus is reinventing growth media for cell culture in cultivated meat and life science.From growth factors to serum-free supplements, we partner with companies looking for media breakthroughs to help accelerate their progress and de-risk their supply chain.🔵 How do we do it better?We use a groundbreaking combination of data science, high-throughput automation and ISO-certified manufacturing to develop ingredients and formulations that reduce costs, eliminate animal-sourced components and enable scale-up.🔵 Why do we do it?Our Mission is to make cultivated meat the sustainable and affordable choice, for everyone.To get there, every cultivated meat company needs to achieve the following growth media milestones:1️⃣ Reduced input costs2️⃣ Use of food-grade, animal-free ingredients that are sustainably sourced and aligned with regulation3️⃣ Optimised formulations to improve bioprocess performance4️⃣ Established scalable feedstocks where supply meets future production plansCompanies that choose Multus see us as an indispensable partner in their journey to scaling cultivated meat production. 

SOSV

IndieBio

UK Research and Innovation

Innovate UK

Zero Carbon Capital

Marinya Capital

Alvaro Martinez Barrio

Sake Bosch

Big Idea Ventures

Mandi Ventures

Asahi Kasei

SynBioVen

Multus

Integrated DNA Technologies is a biotechnology company that provides various products and services for research in the life sciences field.

Integrated DNA Technologies

BioLife Solutions is a leading supplier of cell and gene therapy tools and services, providing biopreservation media products.

BioLife Solutions

Biftek is a company involved in the development of cell culture media and related products for various applications.

Biftek

AviadoBio is a biotechnology company that focuses on developing innovative solutions for cell culture and related bioprocessing applications.

AviadoBio

Senzo Health is a company specializing in the development of advanced cell culture media and solutions for biopharmaceutical production.

Senzo Health

Concert Bio is a biotechnology company focused on developing high-quality cell culture media and supplements for various bioproduction processes.

Concert Bio

Multus is a biotechnology company specializing in the development of growth media supplements for cell culture. Their products aim to improve the scalability and cost-effectiveness of cell-based meat production by providing a more nutritious environment for cell growth, which is essential for the cultivated meat industry.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	May 8, 2024 4:05 AM	bdbbee0f
public peers	general	May 8, 2024 4:05 AM	ca18ed8c
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 8, 2024 4:05 AM	02a971d1
company summary	general
signals	general
crunchbase trigger	general	Nov 12, 2024 12:52 PM	49577a61
crunchbase profile	general
li profile	general	May 8, 2024 4:05 AM	fd5e7b2a
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 8, 2024 4:05 AM	40e2d8a6
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

BIO:MULTUS

Multus